These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25201129)

  • 21. Induction of virus-neutralizing antibodies and T cell responses by dengue virus type 1 virus-like particles prepared from Pichia pastoris.
    Tang YX; Jiang LF; Zhou JM; Yin Y; Yang XM; Liu WQ; Fang DY
    Chin Med J (Engl); 2012 Jun; 125(11):1986-92. PubMed ID: 22884066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive characterization of a major capsid protein derived from a documented GII.6 norovirus strain.
    Zheng L; Wang W; Liu J; Huo Y; Qin C; Wang M; Shen S
    Arch Virol; 2017 Dec; 162(12):3863-3868. PubMed ID: 28866835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.
    Huhti L; Blazevic V; Nurminen K; Koho T; Hytönen VP; Vesikari T
    Arch Virol; 2010 Nov; 155(11):1855-8. PubMed ID: 20721592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
    Poddar A; Ramasamy V; Shukla R; Rajpoot RK; Arora U; Jain SK; Swaminathan S; Khanna N
    BMC Biotechnol; 2016 Jun; 16(1):50. PubMed ID: 27301568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity.
    Masuda A; Man Lee J; Miyata T; Sato S; Masuda A; Taniguchi M; Fujita R; Ushijima H; Morimoto K; Ebihara T; Hino M; Kakino K; Mon H; Kusakabe T
    Vaccine; 2023 Jan; 41(3):766-777. PubMed ID: 36528444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ELISA-Based Methods to Detect and Quantify Norovirus Virus-Like Particle Attachment to Histo-Blood Group Antigens.
    Shirato H
    Methods Mol Biol; 2020; 2132():597-607. PubMed ID: 32306359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two-step purification of tag-free norovirus-like particles from silkworm larvae (Bombyx mori).
    Boonyakida J; Utomo DIS; Soma FN; Park EY
    Protein Expr Purif; 2022 Feb; 190():106010. PubMed ID: 34737040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects.
    Ma S; Zhang F; Zheng L; Liu J; Ma J; Chen X; Yang Z; Wang W; Li L; Wang M; Huo Y
    Virus Genes; 2019 Jun; 55(3):280-289. PubMed ID: 30725444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains.
    Huo Y; Chen X; Zheng L; Huo J; Zhang S; Wang M; Wang Y
    Virus Genes; 2016 Oct; 52(5):613-9. PubMed ID: 27234312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of natural ageing and heat treatments on GII.4 norovirus binding to Histo-Blood Group Antigens.
    Robin M; Chassaing M; Loutreul J; de Rougemont A; Belliot G; Majou D; Gantzer C; Boudaud N
    Sci Rep; 2019 Oct; 9(1):15312. PubMed ID: 31653918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.
    Mani S; Tripathi L; Raut R; Tyagi P; Arora U; Barman T; Sood R; Galav A; Wahala W; de Silva A; Swaminathan S; Khanna N
    PLoS One; 2013; 8(5):e64595. PubMed ID: 23717637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Chimeric HPV-HIV Protein L1P18 in
    Eto Y; Saubi N; Ferrer P; Joseph-Munné J
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification of norovirus-like particles (VLPs) by ion exchange chromatography.
    Koho T; Mäntylä T; Laurinmäki P; Huhti L; Butcher SJ; Vesikari T; Kulomaa MS; Hytönen VP
    J Virol Methods; 2012 Apr; 181(1):6-11. PubMed ID: 22265819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus-like particle production with yeast: ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen.
    Lünsdorf H; Gurramkonda C; Adnan A; Khanna N; Rinas U
    Microb Cell Fact; 2011 Jun; 10():48. PubMed ID: 21703024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Secreted expression of Japanese encephalitis virus prME in Pichia pastoris and immunogenicity evaluation of the virus-like particles in mice].
    Zhao P; Jiang Y; Wang J; Fan H; Cao R
    Sheng Wu Gong Cheng Xue Bao; 2017 May; 33(5):863-874. PubMed ID: 28876040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles.
    Tamminen K; Huhti L; Koho T; Lappalainen S; Hytönen VP; Vesikari T; Blazevic V
    Immunology; 2012 Jan; 135(1):89-99. PubMed ID: 22044070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.
    Kocher J; Bui T; Giri-Rachman E; Wen K; Li G; Yang X; Liu F; Tan M; Xia M; Zhong W; Jiang X; Yuan L
    J Virol; 2014 Sep; 88(17):9728-43. PubMed ID: 24920797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of Norovirus VLPs to size homogeneity.
    Huo Y; Wan X; Wang Z; Meng S; Shen S
    Virus Res; 2015 Jun; 204():1-5. PubMed ID: 25892715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in
    Yang Z; Gao F; Wang X; Shi L; Zhou Z; Jiang Y; Ma X; Zhang C; Zhou C; Zeng X; Liu G; Fan J; Mao Q; Shi L
    Hum Vaccin Immunother; 2020 Jul; 16(7):1602-1610. PubMed ID: 31403352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.